Furthermore, the activation of the AMPK pathway has also demonstrated the ability to restrain dysfunctional vascular growth, a significant contributor to cardiovascular disease, by inhibiting TGF-β [45]. The gene discussed is PRKAA1; the disease is cardiovascular disorder.